Brought to you by 
XenoPort brings in $48.8mm with its IPO
05 Jul 2005
Executive Summary
Xenoport (improves existing drugs) has brought in $48.8mm with the initial public offering of 5mm common shares priced at $10.50 each. The company had originally hoped to bring in $86.25mm when it filed in January of this year.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
XenoPort brings in $48.8mm with its IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice